Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Expands Gold Footprint in BC (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Galectin Therapeutics Inc
GALT
Healthcare
Biotechnology
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2...
clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:GALT)
New Post
View:
Posts & Comments
Threaded Posts
(48)
•••
SPCEO1
X
Post by
SPCEO1
on Jun 25, 2018 11:01am
GALT Issues
The bull case on GALT is simply stated in this manner: 1.) The FDA has allowed them to go to Phase three on the strength of a portion of the data from their Phase II test where the top line was
...more
(48)
•••
SPCEO1
X
Post by
SPCEO1
on Jun 25, 2018 10:24am
Links to articles related to GALT
https://psinvestor.com/galectin-therapeutics-from-an-investor-perspective/ https://emerginggrowth.com/cancers-last-stand-gr-md-02-nearly-doubles-response-rate-added-keytruda/ https://www.fool.com
...more
(0)
•••
BluSignals
X
Post by
BluSignals
on Jun 14, 2018 2:42pm
GALT Trading Signals
Today's rise by 8% was based on the liver therapy provided to patients, which came out with positive numbers. However, other data related to the stock price, volume and the product demand
...more
(4)
•••
goldguy007
X
Comment by
goldguy007
on Jul 30, 2014 10:01am
RE:RE:Galectin Therapeutics (GALT) Comments on GR-MD-02
IGNORE THIS SPAMMER-DOUGLASTILLO
(4)
•••
goldguy007
X
Post by
goldguy007
on Jul 30, 2014 9:29am
Galectin Therapeutics (GALT) Comments on GR-MD-02
Galectin Therapeutics (Nasdaq: GALT) announced yesterday results of cohort 2 of its phase 1 clinical trial in patients with NASH with advanced fibrosis. While the results of the clinical trial were
...more
(4)
•••
goldguy007
X
Post by
goldguy007
on Jul 30, 2014 3:50am
Was The Sell-Off Justified?
Here is the Seeking Alpha story that helped contribute to the selling. Note that the author is long put options on GALT.https://seekingalpha.com/article/2347785-galectin-therapeutics-why-this-penny
...more
(4)
•••
goldguy007
X
Post by
goldguy007
on Jul 30, 2014 3:09am
New Board
Hi I am a shareholder in GALT and I invite everyone interested in the company and shares to post here. I will be posting some interesting info regarding Tuesday's sell-off, soon. goldguy
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF)
Podcasts